Capital International Investors Insmed Inc Transaction History
Capital International Investors
- $488 Billion
- Q1 2025
A detailed history of Capital International Investors transactions in Insmed Inc stock. As of the latest transaction made, Capital International Investors holds 7,198,485 shares of INSM stock, worth $489 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
7,198,485
Previous 7,116,997
1.14%
Holding current value
$489 Million
Previous $491 Million
11.77%
% of portfolio
0.11%
Previous 0.1%
Shares
5 transactions
Others Institutions Holding INSM
# of Institutions
488Shares Held
197MCall Options Held
892KPut Options Held
1.77M-
Vanguard Group Inc Valley Forge, PA18.3MShares$1.24 Billion0.03% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y915.4MShares$1.05 Billion81.63% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$968 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.9MShares$877 Million0.12% of portfolio
-
Jpmorgan Chase & CO New York, NY6.35MShares$431 Million0.04% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.2B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...